KDM1A and neoplasm: Strikingly, combined therapy of anti‐PD1 antibody and LSD1 inhibitor exhibited a more robust inhibition of tumour growth than either anti‐PD1 antibody alone or LSD1 inhibitor alone (Figure 5F).